Which pharma company seeks permission from DGCI for 'phase 2&3' clinic – InterviewSolution

InterviewSolution

1.	Which pharma company seeks permission from DGCI for 'phase 2&3' clinical trials of Oxford vaccine under brand name "Covishield" in India?
Answer» The Serum Institute of India (SII), which has partnered with British-Swedish pharma company AstraZeneca for manufacturing the University of Oxford vaccine candidate for COVID-19, has sought permission from the Drugs Controller General of India (DCGI) for conducting "phase 2/3 human clinical trials" of the potential vaccine.

Discussion

No Comment Found

Related InterviewSolutions

What is the rank of India in 2017 global Multi-dimensional Poverty Index (MPI)?
India signs a 36 million dollar of Loan Agreement with World Bank for this state's Financial Management Capacity Building Programme.
How many agreements are signed between the India and Spain recently?
India has recently signed pact with which country for defence shipbuilding?
Which country will host the first-ever World Ocean Festival?
Prime Minister Narendra Modi has written to President of this country and reaffirmed India's steadfast support to the country in its fight against all forms of terrorism.
Which city airport has been crowned the world's busiest among the single-runway facilities?
India signed a MoU on peaceful uses of outer space and MoU on cooperation in youth matters with this country.
What is the rank of India as per the report of SIPRI military expenditure database?
India's rank in the 2017 World Press Freedom Index (WPFI) is